» Articles » PMID: 7505322

Immunopathogenesis of Chronic Inflammatory Periodontal Disease: Cellular and Molecular Mechanisms

Overview
Specialty Dentistry
Date 1993 Nov 1
PMID 7505322
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies of the cellular mechanisms involved in chronic inflammatory periodontal disease (CIPD) have contributed significantly to our understanding of the pathogenesis of the disease process. Functional studies have demonstrated polymorphonuclear neutrophil (PMN) chemotactic defects in some 70% of subjects with localized juvenile periodontitis while chemiluminescence data have suggested that peripheral blood PMNs from young subjects with adult periodontitis (AP) may be in a metabolically active state. Further studies have shown that stimulation of PMNs with a number of periodontopathic bacteria resulted in the production of an IL-1 inhibitor suggesting a possible regulatory role for PMNs in CIPD in addition to their established protective role. Most work on the immunoregulation of CIPD has, however, concentrated on T-cells. Recent limit dilution analysis has demonstrated the presence of periodontopathic bacteria-specific T cells in peripheral blood and the involvement and homing of these cells to the local lesions of CIPD is currently the focus of many studies. In animal studies, Actinobacillus actinomycetemcomitans (Aa)-specific T-cell clones home to the gingival tissues where they may exert a protective role. Homing and retention of lymphocytes to and in specific sites is dependent upon the expression of adhesion molecules. Recent data indicate however, that while there are increasing levels of ICAM-1, LECAM-1 and PECAM-1 expression with increasing degrees of inflammation, there are no differences between gingivitis and periodontitis lesions. Cytokine profiles may be related to the role of T-cell clones homing to the gingiva in CIPD.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Evaluating the role of inflammatory biomarkers as a diagnostic tool in peri-implantitis.

Saxena A, Rastogi P, Lal N, Verma U, Singhal R, Ahmad M J Oral Biol Craniofac Res. 2025; 15(2):228-233.

PMID: 40008071 PMC: 11849608. DOI: 10.1016/j.jobcr.2025.01.015.


Gingival crevicular fluid level of tumor necrosis factor-alpha as a valuable biomarker for estimation of the efficacy of adjunctive antimicrobial photodynamic therapy in stage II-IV periodontitis: a systematic review and meta-analysis.

Karrabi M, Baghani Z, Assarzadeh H Lasers Med Sci. 2024; 39(1):301.

PMID: 39709576 DOI: 10.1007/s10103-024-04251-4.


Herbal and nano-based herbal medicine: New insights into their therapeutic aspects against periodontitis.

Rezaei-Tazangi F, Forutan Mirhosseini A, Fathi A, Roghani-Shahraki H, Arefnezhad R, Vasei F Avicenna J Phytomed. 2024; 14(4):430-454.

PMID: 38952769 PMC: 11179182. DOI: 10.22038/AJP.2023.23261.


Association of Periodontitis and Atopic Dermatitis with the Levels of IL-13, IL-31, and TSLP in the Gingival Crevicular Fluid.

Jimenez C, Fernandez J, Aroca M, Bordagaray M, Pellegrini E, Contador J Int J Mol Sci. 2023; 24(21).

PMID: 37958576 PMC: 10650793. DOI: 10.3390/ijms242115592.


Comparison of mast cell counts between the patients with moderate and severe periodontitis.

Fattahi S, Sadighi M, Faramarzi M, Karimifard E, Mirzaie A J Adv Periodontol Implant Dent. 2022; 11(1):34-38.

PMID: 35919622 PMC: 9327469. DOI: 10.15171/japid.2019.006.